Northwestern investigators are exploring the potential of bacterial toxins to be turned into therapeutic agents to effectively ward off disease.
Browsing: Disease Discoveries
According to a recent study, Northwestern scientists have pinpointed how an ectoenzyme called CD73 undermines the effectiveness of an emerging cancer therapy.
A Northwestern Medicine study has demonstrated the role of dopamine in the progression of glioblastoma and suggests that targeting the neurotransmitter may slow cancer growth.
According to a recent study, significant changes or drops in income can increase the risk of cardiovascular disease, suggesting people in those situations should be a priority for interventions such as screenings.
A genome-wide analysis revealed nine new genes associated with fragile X syndrome, findings that shed light on the complex hereditary mechanisms behind the genetic disease.
A Northwestern Medicine study provides new insights into a signaling pathway in metastatic prostate cancer and suggests that a novel drug combination may improve treatment response and slow cancer growth.
Northwestern Medicine scientists demonstrated how innate immune cells in inflamed tissue induce DNA damage that promotes the development of cancer.
Kelly Wun, a fourth-year medical student, was the first author of a study that links the microbiome to the development of restenosis, the renarrowing of arteries after a procedure.
Northwestern Medicine scientists have identified a gene, called isocitrate dehydrogenase 3-alpha, that promotes tumors in grade IV glioblastoma, according to a study published in Science Advances.
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing and tissue repair after heart attack, in a study published in Cell Metabolism.